Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes

JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28.

Authors

Pelin Cinar¹, John Cox², Arif Kamal³, Kathleen Bickel⁴, Monika Krzyzanowska⁵, James Armitage⁶, Apar Kishor Ganti⁷, Jeffery Ward⁸, Sandra Wong⁹, Sagar Lonial¹⁰, Linda Bosserman¹¹

Affiliations

¹ University of California San Francisco, San Francisco, CA.
² University of Texas Southwestern Medical Center at Dallas, Dallas, TX.
³ Duke-NUS Medical School, Singapore.
⁴ Anschutz Medical Campus, University of Colorado Denver, Denver, CO.
⁵ Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
⁶ College of Medicine, University of Nebraska Medical Center, Omaha, NE.
⁷ University of Nebraska Medical Center, Omaha, NE.
⁸ Swedish Cancer Institute, Seattle, WA.
⁹ Dartmouth-Hitchcock Medical Center, Lebanon, NH.
¹⁰ Winship Cancer Institute, Emory University, Atlanta, GA.
¹¹ City of Hope National Cancer Center, Duarte, CA.

PMID: 32463764
DOI: 10.1200/OP.20.00326

No abstract available

Publication types

Editorial

MeSH terms

Betacoronavirus / pathogenicity
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / epidemiology*
Coronavirus Infections / therapy
Coronavirus Infections / virology
Humans
Medical Oncology*
Neoplasms / complications
Neoplasms / epidemiology*
Neoplasms / therapy
Neoplasms / virology
Pandemics*
Pneumonia, Viral / complications
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / therapy
Pneumonia, Viral / virology
SARS-CoV-2